Company / Total Assets
Aligos Therapeutics, Inc. Total Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$88.5M
FY2025
5-year range
$70.1M / $235.4M
FY2021-FY2025
Trend
+26.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 6 years, ranging from $70M in FY2024 to $265M in FY2020.
Based on SEC 10-K filings.
$89M in FY2025 with a 5-year CAGR of -19.7%.
Declined from $152M to $89M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -15.5%
- 5-Year CAGR
- -19.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -19.7%, indicating a declining trend.
- In FY2025, total assets increased 26.3% year-over-year.
- Peak total assets was recorded in FY2020.
- Lowest total assets in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $88.5M | +26.3% |
| FY2024 | $70.1M | -53.7% |
| FY2023 | $151.5M | +3.3% |
| FY2022 | $146.7M | -37.7% |
| FY2021 | $235.4M | -11.3% |
| FY2020 | $265.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026